Works matching IS 20401116 AND DT 2025 AND VI 16 AND IP 2


Results: 24
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population.

    Published in:
    Journal of Diabetes Investigation, 2025, v. 16, n. 2, p. 298, doi. 10.1111/jdi.14351
    By:
    • Suzuki, Keita;
    • Tsujiguchi, Hiromasa;
    • Hara, Akinori;
    • Takeshita, Yumie;
    • Goto, Hisanori;
    • Nakano, Yujiro;
    • Yamamoto, Reina;
    • Takayama, Hiroaki;
    • Tajima, Atsushi;
    • Yamashita, Tatsuya;
    • Honda, Masao;
    • Nakamura, Hiroyuki;
    • Takamura, Toshinari
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?

    Published in:
    Journal of Diabetes Investigation, 2025, v. 16, n. 2, p. 343, doi. 10.1111/jdi.14325
    By:
    • Yamamoto, Yukako;
    • Sekine, Osamu;
    • Ito‐Kobayashi, Jun;
    • Nishida, Ayane;
    • Togawa, Takeshi;
    • Ozamoto, Yuki;
    • Oe, Yasumitsu;
    • Hagiwara, Akeo;
    • Kobayashi, Masaki;
    • Kitamura, Tadahiro;
    • Iwanishi, Masanori;
    • Shimatsu, Akira;
    • Kashiwagi, Atsunori
    Publication type:
    Article
    24

    Issue Information.

    Published in:
    Journal of Diabetes Investigation, 2025, v. 16, n. 2, p. 169, doi. 10.1111/jdi.14235
    Publication type:
    Article